37 Pascal Crescent, Reading
Terraced house · Freehold · RG2 9FP
Sold for £335,000 in December 2007.
Indexed with the UK House Price Index for Wokingham, that sale is worth about £558,300 today. The 94 terraced houses counted in RG2 9 over the last 24 months sold for a median of £4,850 per square metre. No energy certificate matches this address, so there is no floor area and no price per square metre; its sold prices are shown in full.
Sale history
HM Land Registry · 1 sale since 1995| Date | Price paid | £ / m² | Growth / yr | After inflation | Today's value |
|---|---|---|---|---|---|
| Dec 2007New build | £335,000 | — | — | — | £558,300 |
Growth is the compound annual rate between one sale and the next, shown when they are at least a year apart; after inflation uses CPIH for the same months. Today's value indexes each sale forward with the UK House Price Index for Wokingham to August 2026.
Recent sales in RG2 9
Newest first| Address | Date | Price | Size | £ / m² |
|---|---|---|---|---|
| 51 Chestnut Crescent | Sep 2026 | £430,000 | 101 m² | £4,260 |
| 26 Cutbush Lane West | Sep 2026 | £842,000 | 179 m² | £4,700 |
| 3 Vickers Close | Sep 2026 | £555,000 | 112 m² | £4,960 |
| 5 Appleton Way | Sep 2026 | £560,000 | 143 m² | £3,920 |
| 22 Ilbury Close | Sep 2026 | £408,000 | 92 m² | £4,430 |
| 10 Grenadier Close | Sep 2026 | £762,000 | 172 m² | £4,430 |
| 6 Pintail Place | Sep 2026 | £425,000 | 82 m² | £5,180 |
| Flat 8, The Stables, 1 Bridle Road | Sep 2026 | £265,000 | — | — |
| 3 Denbigh Place | Sep 2026 | £398,000 | 79 m² | £5,040 |
| 12 Fairmead Road | Sep 2026 | £605,000 | 127 m² | £4,760 |
About this page
What did 37 Pascal Crescent sell for? 37 Pascal Crescent last sold for £335,000 in December 2007. Price per square metre is the price paid divided by that area; today's value indexes the latest sale forward with the UK House Price Index. None of these figures is a valuation.
Sales to September 2026 · HM Land Registry price paid data · MHCLG energy certificates · UK House Price Index to August 2026 · An index-based comparison of sold prices, not a valuation.